ADHERIS HEALTH LIMITED — Call Transcript 2021

Aug 26, 2021

MedAdvisor Limited ACN 145 327 617 Level 2, 971 Burke Road Camberwell Vic 3124 mymedadvisor.com/investors

==> picture [206 x 42] intentionally omitted <==

MARKET RELEASE

MedAdvisor FY21 Results Call Details

Melbourne, Australia, 27 August, 2021 - Medtech company, MedAdvisor Limited (ASX: MDR) will host its FY21 results call on Monday 30[th] August at 11:30am.

Investors are invited to register for the call using this link -

https://us02web.zoom.us/webinar/register/WN_gkGULiUxRZq4tWSgF7dtHQ

Addressing investors will be MedAdvisor Chair, Chris Ridd, CEO Robert Read and CFO Simon Glover.

Results and the presentation will be available on the ASX prior to the webinar.

• ENDS –

This document has been authorised for release by Naomi Lawrie, MedAdvisor Company Secretary.

About MedAdvisor

MedAdvisor is a world-class medication management platform that empowers patients to more simply manage their medication and improve adherence. MedAdvisor’s highly automated and intuitive software system connects patients to tools and education materials from their preferred pharmacy. MedAdvisor works with 25,000 pharmacies in the US to deliver programs to help patients take their medication safely and effectively. In Australia, MedAdvisor has connected over 1.9 million patients through more than 65% of Australian pharmacies. MedAdvisor has partnered with HMS in the US and is on track to become one of the largest players in the global digital adherence market. In 2018 and 2020, MedAdvisor was recognised in the AFR Fast 100. Visit: mymedadvisor.com/investors

For more information:

Simon Glover Chief Financial Officer corporate@medadvisor.com.au +61 3 905 3036